Skip to main content
Tag

All.can

All.Can infographic answers why efficient cancer care matters

By News archive

A new infographic published by the All.Can initiative explains why cancer care efficiency matters and how it can be improved. As highlighted in the graphic, efficient cancer care delivers the best possible health outcomes using the human, financial, infrastructural and technological resources available. As well as highlighting the many negative consequences of inefficient cancer care, the graphic illustrates six ways in which greater efficiency can be achieved in cancer care.

All.Can was an initiative established in 2016, in which the IBTA is a founding member, and is a global, multi-stakeholder initiative to inform and generate political and public engagement on the need to improve efficiency in cancer care, by focusing on what really matters to patients and society. All.Can seeks to make sure resources are directed towards achieving better health outcomes while contributing to health systems’ overall sustainability.

Download the full infographic here.

Read more on the All.Can website here.

First findings of All.Can patient survey presented at UK Parliament event

By IBTA News

The All.Can initiative has presented the first findings of its UK patient survey at a UK Parliamentary event. They showed that 36% of people considered the cancer diagnosis stage as the biggest cause of inefficiency in their care. Two in five people with cancer had been initially misdiagnosed with something else – sometimes on multiple occasions – and one in five had to wait more than six months for a cancer diagnosis.

The findings were presented at the Britain Against Cancer conference, hosted by the All-Party Parliamentary Group on Cancer. The event took place on 4 December at the UK Parliament in London. The UK national initiative is the first of nine countries to release findings from the All.Can patient survey, which sought patients’ and carers’ perspectives on inefficiencies in cancer care.

All.Can is an international multi-stakeholder policy initiative that is focused on improving efficiency in cancer care, in which the IBTA is one of the stakeholder organisations. The UK national initiative is the first of nine countries to release findings from the All.Can patient survey. A report of the findings from all countries is due to be published in early 2019. Read more.